CREB3L1 anticorps (C-Term)

N° du produit ABIN5533846

Détail du produit anti-CREB3L1 anticorps

Antigène: CREB3L1 (CAMP Responsive Element Binding Protein 3-Like 1 (CREB3L1))

Épitope: AA 491-519, C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CREB3L1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Purification: This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis

Immunogène: This OASIS antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 491-519 amino acids from the C-terminal region of human OASIS.

Isotype: Ig Fraction

Information d'application

Indications d'application: For WB starting dilution is: 1:1000

For IHC-P starting dilution is: 1:50~100

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1.87 mg/mL

Buffer: Supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur CREB3L1

Antigène: CREB3L1 (CAMP Responsive Element Binding Protein 3-Like 1 (CREB3L1))

Autre désignation: OASIS (CREB3L1 Produits)

Synonymes: anticorps CREB3L1, anticorps OASIS, anticorps Oasis, anticorps diacylglycerol kinase-like, anticorps cAMP responsive element binding protein 3 like 1, anticorps cAMP responsive element binding protein 3-like 1, anticorps LOC423198, anticorps CREB3L1, anticorps Creb3l1

Sujet: OASIS is a putative CREB/ATF family transcription factor with a putative C-terminal hydrophobic transmembrane domain. It can activate transcription through box-B elements but not through CRE of somatostatin. Shortening of the OASIS transmembrane domain results in a significant increase in transcriptional activity and changes its subcellular localization from the endoplasmic reticulum to the nucleus.

Poids moléculaire: 57 kDa

ID gène: 90993

UniProt: Q96BA8

Pathways: Thyroid Hormone Synthesis, Chromatin Binding